Ulcerative Colitis: Epidemiology and Growth Trends, 2019-2022 & 2023-2032

News provided by

Aug 25, 2023, 10:45 ET

DUBLIN, Aug. 25, 2023 /PRNewswire/ -- The "Ulcerative Colitis (UC) - Epidemiology Forecast to 2032" report has been added to ResearchAndMarkets.com's offering.

This comprehensive report is a valuable resource for stakeholders in the healthcare and technology domains. It furnishes a detailed understanding of Ulcerative Colitis epidemiology and offers insights into growth trends and potential strategies for informed decision-making.

The 7 major markets (7MM) are expected to see diagnosed prevalent cases grow from ~3,012,740 in 2022 to ~4,176,530 by 2032. This surge is underpinned by factors such as the increasing demand for data centers and the imperative need for real-time asset information to mitigate potential risks.

The categorization of Ulcerative Colitis into mild and moderate to severe subtypes is a critical facet of its severity-specific analysis. Within the 7MM, the count of mild cases is poised to rise from ~1,205,100 in 2022 to ~1,670,610 by 2032. Similarly, the tally of moderate to severe cases is projected to increase from ~1,988,410 in 2022 to ~2,756,510 by 2032. The United States plays a pivotal role in this trend, accounting for a substantial share of diagnosed prevalent cases across diverse age groups.

Treatment trends reflect a corresponding growth trajectory. In the United States, treated cases are set to rise in various treatment lines. By 2032, mild cases are projected to reach ~822,774, while moderate-to-severe cases in the first, second, and third lines are expected to touch ~1,221,819, ~378,764, and ~128,780, respectively.

The North American region, particularly the United States, emerges as a frontrunner in Ulcerative Colitis prevalence and forecast. This region's prominence is buoyed by technological advancements like RFID technology, which facilitates asset tracking and optimizes fleet management.

Key Topics Covered

1. Key Insights

2. Report Introduction

3. Epidemiology Methodology

4. Executive Summary of Ulcerative Colitis

5. Disease Background and Overview
5.1. Introduction
5.2. Types of Ulcerative Colitis
5.3. Classification of Ulcerative Colitis
5.4. Signs and Symptoms of Ulcerative Colitis
5.5. Risk Factors and Causes of Ulcerative Colitis
5.5. Pathophysiology of Ulcerative Colitis
5.7. Complications of Ulcerative Colitis
5.8. Severity Scoring System
5.9. Diagnosis
5.9.1. Differential Diagnosis
5.9.2. Antibody Blood Tests (Biomarkers)
5.10. Diagnostic Guidelines of Ulcerative Colitis
5.10.1. American College of Gastroenterology (ACG) Guidelines
5.10.2. European Crohn's and Colitis Organization (Journal of Crohn's and Colitis)

6. Epidemiology and Patient Population
6.1. Key Findings
6.2. Assumptions and Rationale
6.3. Total Diagnosed Prevalent Cases of Ulcerative Colitis in the 7MM
6.4. Epidemiology Scenario in the United States
6.4.1. Total Diagnosed Prevalent Cases of Ulcerative Colitis in the United States
6.4.2. Age-specific Cases of Ulcerative Colitis in the United States
6.4.3. Severity-specific Cases of Ulcerative Colitis in the United States
6.4.4. Total Treated Patients of Ulcerative Colitis in the United States
6.5. Epidemiology Scenario in EU4 and the UK
6.5.1. Total Diagnosed Prevalent Cases of Ulcerative Colitis in EU4 and the UK
6.5.2. Age-specific Cases of Ulcerative Colitis in EU4 and the UK
6.5.3. Severity-specific Cases of Ulcerative Colitis in EU4 and the UK
6.5.4. Total Treated Cases of Ulcerative Colitis in EU4 and the UK
6.6. Epidemiology Scenario in Japan
6.6.1. Total Diagnosed Prevalent Cases of Ulcerative Colitis in Japan
6.6.2. Age-specific Cases of Ulcerative Colitis in Japan
6.6.3. Severity-specific Cases of Ulcerative Colitis in Japan
6.6.4. Total Treated Cases of Ulcerative Colitis in Japan

7. Appendix
7.1. Report Methodology
7.2. Bibliography

For more information about this report visit https://www.researchandmarkets.com/r/wwtpqg

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets